Back to
Gabelli Funds LLC
UTHR5 quarters
Position history for
Gabelli Funds LLC's holdings in United Therapeutics Corporation
No. Gabelli Funds exited its UTHR (United Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 3,000 shares worth $284,000. Gabelli Funds first reported UTHR in Q2 2019 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$390,000
Total Shares Change
-5,000
Quarter-by-Quarter History
Other major holders of UTHR: BlackRock, Inc., Vanguard Group Inc.